171 related articles for article (PubMed ID: 8626353)
1. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
Keck PE; Nabulsi AA; Taylor JL; Henke CJ; Chmiel JJ; Stanton SP; Bennett JA
J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
[TBL] [Abstract][Full Text] [Related]
2. Health-economic implications of the onset of action of antimanic agents.
Keck PE; McElroy SL; Bennett JA
J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
Conney J; Kaston B
Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
[TBL] [Abstract][Full Text] [Related]
5. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
[TBL] [Abstract][Full Text] [Related]
6. A medication algorithm for treatment of bipolar rapid cycling?
Calabrese JR; Woyshville MJ
J Clin Psychiatry; 1995; 56 Suppl 3():11-8. PubMed ID: 7883737
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder.
Schumock GT; Walton SM; Gupta SR; Cramer JA
Curr Med Res Opin; 2007 Aug; 23(8):1997-2004. PubMed ID: 17637202
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
10. Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials.
Caro JJ; Huybrechts KF; Xenakis JG; O'Brien JA; Rajagopalan K; Lee K
Curr Med Res Opin; 2006 Nov; 22(11):2233-42. PubMed ID: 17076984
[TBL] [Abstract][Full Text] [Related]
11. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
12. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
Goodwin FK
J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
[TBL] [Abstract][Full Text] [Related]
13. Divalproex sodium in the treatment of refractory affective disorders.
Schaff MR; Fawcett J; Zajecka JM
J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
[TBL] [Abstract][Full Text] [Related]
14. Is divalproex a cost-effective alternative in the acute and prophylactic treatment of bipolar I disorder?
Dardennes RM; Even C
J Clin Psychiatry; 1997 Nov; 58(11):495-6. PubMed ID: 9413417
[No Abstract] [Full Text] [Related]
15. [Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
Swann AC
Encephale; 2001; 27(3):277-9. PubMed ID: 11488258
[TBL] [Abstract][Full Text] [Related]
16. Divalproex sodium vs. valproic acid: drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorder.
Iqbal SU; Cunningham F; Lee A; Wang S; Hamed A; Miller DR; Ren X; Kazis L
J Clin Pharm Ther; 2007 Dec; 32(6):625-32. PubMed ID: 18021341
[TBL] [Abstract][Full Text] [Related]
17. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
18. Predictors of response to divalproex and lithium.
Bowden CL
J Clin Psychiatry; 1995; 56 Suppl 3():25-30. PubMed ID: 7883739
[TBL] [Abstract][Full Text] [Related]
19. Divalproex in the treatment of bipolar disorder.
Keck PE; McElroy SL
Psychopharmacol Bull; 2003; 37 Suppl 2():67-73. PubMed ID: 15021862
[TBL] [Abstract][Full Text] [Related]
20. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
Sachs GS; Printz DJ; Kahn DA; Carpenter D; Docherty JP
Postgrad Med; 2000 Apr; Spec No():1-104. PubMed ID: 10895797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
